睿禾健康科技（杭州）有限公司成立于2025年，致力于解决预防医疗领域最核心的商业化难题——如何将预防干预的效果，转化为支付体系可接受的因果证据。我们不是又一家健康管理公司，我们是让健康管理能被结算的基础设施。Founded in Hangzhou in 2025, ReHealth AI is building the infrastructure to solve preventive medicine's core commercialization challenge — converting intervention outcomes into causal evidence accepted by healthcare payers. We're not another health management company. We're the infrastructure that makes health management billable.
"预防胜于治疗"是医学界最古老的共识，但这个共识从来没有被转化为支付体系的语言。我们的使命是给预防一个"价格标签"——用可验证的因果证据，让支付方为预防买单。"Prevention is better than cure" is medicine's oldest consensus, but it has never been translated into payer language. Our mission: give prevention a price tag through verifiable causal evidence that makes payers willing to pay.
我们不做健康管理App，不做体检平台，不做穿戴设备。我们做的是让所有这些工具产出的数据能被串联成因果链路、最终转化为可结算证据的底层基础设施。电力不是家电，支付宝不是商店——ReHealth Core 是预防医疗的"支付轨道"。We don't build health apps, checkup platforms, or wearables. We build the underlying infrastructure that chains all their data into causal pathways and converts it into billable evidence. Electricity isn't an appliance; Alipay isn't a store — ReHealth Core is preventive medicine's "payment rail."
市场上充斥着"参与者更健康"的相关性数据，但支付方不买单。ReHealth Core 用倾向评分匹配（PSM）消除选择偏倚，量化干预的真实因果效应。因果证据是我们的核心壁垒，也是行业的必经之路。The market is flooded with "participants are healthier" correlation data, but payers don't pay. We use PSM to eliminate selection bias and quantify true causal effects. Causal evidence is our core barrier and the industry's inevitable path.
联邦学习架构下，患者原始数据永远不出域。差分隐私保护模型梯度。三法合规不是竞争优势，而是做医疗AI的最低标准。我们从第一天就按这个标准构建。Under federated learning, raw patient data never leaves the institution. Differential privacy protects model gradients. Triple-law compliance isn't a competitive advantage — it's the minimum standard for medical AI. We've built to this standard from day one.
团队覆盖AI算法、临床医学、医疗器械商业化全链路，具备从模型研发到产品注册到商业落地的完整执行能力。Our team covers AI algorithms, clinical medicine, and medical device commercialization end-to-end — from model R&D to regulatory registration to commercial deployment.
联邦学习架构，患者原始数据始终留存于机构本地。Federated learning: raw patient data stays on-premise at all times.
满足《个保法》《数安法》《网安法》。Compliant with PIPL, DSL, and CSL.
因果报告符合NMPA真实世界证据指导原则（2020）。Reports meet NMPA RWE guidelines (2020).
覆盖预测、联邦学习、归因与结算机制。Covering prediction, FL, attribution, and settlement.
软件医疗器械注册备案中。Medical device software registration in progress.
种子轮已完成，战略投资方深耕医疗健康。Seed round closed with strategic healthcare investor.
中国浙江省杭州市Hangzhou, Zhejiang, China
无论您是医院、保险公司、企业雇主还是药企，ReHealth Core 都能为您提供从预测到结算的完整闭环支持。Whether you're a hospital, insurer, employer, or pharma company, ReHealth Core provides full closed-loop support from prediction to settlement.